日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/10/11 | 7,540 | 7,670 | 7,510 | 7,600 | -50 | -0.7% | 181,700 |
| 2022/10/07 | 7,580 | 7,650 | 7,560 | 7,650 | -80 | -1% | 205,900 |
| 2022/10/06 | 7,710 | 7,850 | 7,710 | 7,730 | +100 | +1.3% | 239,500 |
| 2022/10/05 | 7,600 | 7,660 | 7,490 | 7,630 | +40 | +0.5% | 211,400 |
| 2022/10/04 | 7,530 | 7,610 | 7,500 | 7,590 | +230 | +3.1% | 217,400 |
| 2022/10/03 | 7,320 | 7,370 | 7,210 | 7,360 | -40 | -0.5% | 165,700 |
| 2022/09/30 | 7,500 | 7,520 | 7,370 | 7,400 | -20 | -0.3% | 157,100 |
| 2022/09/29 | 7,220 | 7,460 | 7,160 | 7,420 | +280 | +3.9% | 210,500 |
| 2022/09/28 | 7,170 | 7,250 | 7,030 | 7,140 | -40 | -0.6% | 205,800 |
| 2022/09/27 | 7,100 | 7,200 | 7,060 | 7,180 | +80 | +1.1% | 285,900 |
| 2022/09/26 | 7,130 | 7,270 | 7,070 | 7,100 | -110 | -1.5% | 315,900 |
| 2022/09/22 | 7,250 | 7,290 | 7,130 | 7,210 | -160 | -2.2% | 189,200 |
| 2022/09/21 | 7,310 | 7,410 | 7,280 | 7,370 | -90 | -1.2% | 150,700 |
| 2022/09/20 | 7,560 | 7,580 | 7,410 | 7,460 | -90 | -1.2% | 102,800 |
| 2022/09/16 | 7,470 | 7,580 | 7,430 | 7,550 | +80 | +1.1% | 159,600 |
| 2022/09/15 | 7,450 | 7,510 | 7,410 | 7,470 | -20 | -0.3% | 105,600 |
| 2022/09/14 | 7,530 | 7,550 | 7,480 | 7,490 | -150 | -2% | 116,500 |
| 2022/09/13 | 7,570 | 7,670 | 7,570 | 7,640 | +50 | +0.7% | 89,900 |
| 2022/09/12 | 7,720 | 7,720 | 7,580 | 7,590 | -70 | -0.9% | 109,400 |
| 2022/09/09 | 7,570 | 7,820 | 7,570 | 7,660 | +90 | +1.2% | 241,400 |
| 2022/09/08 | 7,500 | 7,590 | 7,450 | 7,570 | +140 | +1.9% | 173,100 |
| 2022/09/07 | 7,280 | 7,440 | 7,250 | 7,430 | +80 | +1.1% | 195,500 |
| 2022/09/06 | 7,470 | 7,510 | 7,350 | 7,350 | -150 | -2% | 181,000 |
| 2022/09/05 | 7,500 | 7,630 | 7,440 | 7,500 | -70 | -0.9% | 200,000 |
| 2022/09/02 | 7,620 | 7,630 | 7,480 | 7,570 | ±0 | ±0% | 188,900 |
| 2022/09/01 | 7,580 | 7,680 | 7,540 | 7,570 | -80 | -1% | 182,100 |
| 2022/08/31 | 7,420 | 7,660 | 7,410 | 7,650 | +150 | +2% | 289,200 |
| 2022/08/30 | 7,450 | 7,540 | 7,430 | 7,500 | +40 | +0.5% | 152,300 |
| 2022/08/29 | 7,450 | 7,500 | 7,450 | 7,460 | -180 | -2.4% | 104,200 |
| 2022/08/26 | 7,650 | 7,670 | 7,620 | 7,640 | -70 | -0.9% | 97,000 |
| 2022/08/25 | 7,870 | 7,870 | 7,700 | 7,710 | -10 | -0.1% | 118,100 |
| 2022/08/24 | 7,810 | 7,890 | 7,720 | 7,720 | -70 | -0.9% | 165,100 |
| 2022/08/23 | 7,860 | 7,860 | 7,740 | 7,790 | -10 | -0.1% | 122,400 |
| 2022/08/22 | 7,650 | 7,820 | 7,650 | 7,800 | +50 | +0.6% | 86,300 |
| 2022/08/19 | 7,710 | 7,760 | 7,680 | 7,750 | +40 | +0.5% | 115,800 |
| 2022/08/18 | 7,740 | 7,770 | 7,690 | 7,710 | -110 | -1.4% | 141,300 |
| 2022/08/17 | 7,810 | 7,880 | 7,750 | 7,820 | -50 | -0.6% | 186,700 |
| 2022/08/16 | 7,880 | 7,930 | 7,810 | 7,870 | +50 | +0.6% | 141,100 |
| 2022/08/15 | 7,860 | 7,870 | 7,800 | 7,820 | -40 | -0.5% | 107,600 |
| 2022/08/12 | 7,820 | 7,910 | 7,800 | 7,860 | -40 | -0.5% | 208,500 |
| 2022/08/10 | 8,000 | 8,050 | 7,870 | 7,900 | -20 | -0.3% | 291,800 |
| 2022/08/09 | 7,970 | 8,020 | 7,890 | 7,920 | +30 | +0.4% | 136,300 |
| 2022/08/08 | 7,900 | 7,950 | 7,820 | 7,890 | -20 | -0.3% | 151,700 |
| 2022/08/05 | 7,920 | 7,980 | 7,800 | 7,910 | +10 | +0.1% | 150,700 |
| 2022/08/04 | 7,840 | 7,960 | 7,790 | 7,900 | +200 | +2.6% | 183,600 |
| 2022/08/03 | 7,750 | 7,830 | 7,670 | 7,700 | -160 | -2% | 406,600 |
| 2022/08/02 | 8,160 | 8,180 | 7,820 | 7,860 | -400 | -4.8% | 258,400 |
| 2022/08/01 | 8,190 | 8,260 | 8,120 | 8,260 | +40 | +0.5% | 138,400 |
| 2022/07/29 | 8,310 | 8,380 | 8,150 | 8,220 | -100 | -1.2% | 150,200 |
| 2022/07/28 | 8,280 | 8,360 | 8,230 | 8,320 | +20 | +0.2% | 145,200 |
651～
700
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
